Literature DB >> 2910777

Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix.

K Crickard1, M J Niedbala, U Crickard, M Yoonessi, A A Sandberg, K Okuyama, R J Bernacki, S K Satchidanand.   

Abstract

Six cell lines were established from four patients with advanced carcinoma of the ovary and from one patient with carcinoma of the endometrium. These lines were established from fresh tumor material maintained initially on culture dishes coated with an extracellular matrix (ECM) produced by bovine corneal endothelial cells. Two of the six lines continue to require ECM as a substrate for optimal growth while the remaining four lines will proliferate on ECM or plastic substrate. Four cell lines transplanted into athymic nude mice were tumorigenic and maintained histologic and karyotypic similarities between the patient's original tumor, the cell line, and the transplantable tumor. Furthermore, in vitro degradation of ECM was grossly apparent by those cell lines which formed nude mice xenografts. Tumor cells were characterized by cytology, transmission electron microscopy, karyology, substrate requirements, steroid binding protein analysis, and morphological appearance in culture.

Entities:  

Mesh:

Year:  1989        PMID: 2910777     DOI: 10.1016/s0090-8258(89)80028-9

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Implications for clinical pharmacodynamic studies of the statistical characterization of an in vitro antiproliferation assay.

Authors:  L M Levasseur; H Faessel; H K Slocum; W R Greco
Journal:  J Pharmacokinet Biopharm       Date:  1998-12

2.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

3.  Binding of synthetic sulfated ligands by human splenic galectin 1, a beta-galactoside-binding lectin.

Authors:  H J Allen; H Ahmed; K L Matta
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

4.  Three-dimensional culture of a mixed mullerian tumor of the ovary: expression of in vivo characteristics.

Authors:  T J Goodwin; T L Prewett; G F Spaulding; J L Becker
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

5.  Parabolic growth patterns in 96-well plate cell growth experiments.

Authors:  H M Faessel; L M Levasseur; H K Slocum; W R Greco
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-05       Impact factor: 2.416

6.  A polarized human endometrial cell line that binds and transports polymeric IgA.

Authors:  J M Ball; Z Moldoveanu; L R Melsen; P A Kozlowski; S Jackson; M J Mulligan; J F Mestecky; R W Compans
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

7.  Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers.

Authors:  A Sharma; N L Straubinger; R M Straubinger
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

8.  Novel taxol formulations: preparation and characterization of taxol-containing liposomes.

Authors:  A Sharma; R M Straubinger
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

Review 9.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

10.  Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometry.

Authors:  Haoying Yu; Robert M Straubinger; Jin Cao; Hao Wang; Jun Qu
Journal:  J Chromatogr A       Date:  2008-09-19       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.